Product Images Tranexamic Acid
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Tranexamic Acid NDC 69918-301 by Amring Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - tranexamic 01
Figure 1 - tranexamic 02
This is a graph presenting the mean menstrual blood loss (in mL) for different treatments in 3-cycle and 6-cycle studies. The treatments include Tranexamic acid (3900 mg/day) and a placebo. The graph shows a decreasing trend in mean menstrual blood loss for Tranexamic acid treatment compared to the placebo. The x-axis shows different treatment periods, while the y-axis shows the mean menstrual blood loss in mL.*
Principal Display Panel - 30 Tablet Bottle Label - tranexamic 03
This text is a product label for "Tranexamic Acid USP" tablets, which are manufactured by Amring Pharmaceuticals Inc. These tablets are for prescription use only and should be taken three times daily (3.9 g/day) during menstruation. Each tablet contains 650 mg of tranexamic acid. The label provides specific storage instructions, advising the tablets to be kept at 25°C (77°F), with excursions permitted between 15°-30°C (59°-86°F). For complete usage and prescribing information, the package insert should be consulted.*
Company Label - tranexamic 04
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.